Published in Biol Psychiatry on January 11, 2008
Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide. Neurosci Biobehav Rev (2009) 2.44
Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction. Mol Psychiatry (2012) 2.07
A reverse-translational study of dysfunctional exploration in psychiatric disorders: from mice to men. Arch Gen Psychiatry (2009) 1.69
Markers of inflammation and stress distinguish subsets of individuals with schizophrenia and bipolar disorder. Transl Psychiatry (2014) 1.59
Identifying gene regulatory networks in schizophrenia. Neuroimage (2010) 1.34
Target identification for CNS diseases by transcriptional profiling. Neuropsychopharmacology (2008) 1.32
Is aberrant functional connectivity a psychosis endophenotype? A resting state functional magnetic resonance imaging study. Biol Psychiatry (2013) 1.31
Analysis of miR-137 expression and rs1625579 in dorsolateral prefrontal cortex. J Psychiatr Res (2013) 1.20
Gene function analysis in complex data sets using ErmineJ. Nat Protoc (2010) 1.16
Two gene co-expression modules differentiate psychotics and controls. Mol Psychiatry (2012) 1.15
Mitochondria, oligodendrocytes and inflammation in bipolar disorder: evidence from transcriptome studies points to intriguing parallels with multiple sclerosis. Neurobiol Dis (2011) 1.11
Responder and nonresponder patients exhibit different peripheral transcriptional signatures during major depressive episode. Transl Psychiatry (2012) 1.08
Are Bipolar Disorder and Schizophrenia Neuroanatomically Distinct? An Anatomical Likelihood Meta-analysis. Front Hum Neurosci (2010) 1.08
Gene expression profiling by mRNA sequencing reveals increased expression of immune/inflammation-related genes in the hippocampus of individuals with schizophrenia. Transl Psychiatry (2013) 1.07
Systematic review of genome-wide gene expression studies of bipolar disorder. BMC Psychiatry (2013) 1.06
Immune system gene dysregulation in autism and schizophrenia. Dev Neurobiol (2012) 1.04
Molecular identification of hydroxylysine kinase and of ammoniophospholyases acting on 5-phosphohydroxy-L-lysine and phosphoethanolamine. J Biol Chem (2012) 1.01
Canonical correlation analysis for RNA-seq co-expression networks. Nucleic Acids Res (2013) 1.01
Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review. Mol Psychiatry (2016) 0.96
Identifying disease associations via genome-wide association studies. BMC Bioinformatics (2009) 0.96
The first decade and beyond of transcriptional profiling in schizophrenia. Neurobiol Dis (2011) 0.95
MIR137 variants identified in psychiatric patients affect synaptogenesis and neuronal transmission gene sets. Mol Psychiatry (2014) 0.94
Association of rare variation in the glutamate receptor gene SLC1A2 with susceptibility to bipolar disorder and schizophrenia. Eur J Hum Genet (2014) 0.94
Meta-analysis of gene coexpression networks in the post-mortem prefrontal cortex of patients with schizophrenia and unaffected controls. BMC Neurosci (2013) 0.90
Reduced myelin basic protein and actin-related gene expression in visual cortex in schizophrenia. PLoS One (2012) 0.88
Better understanding of mechanisms of schizophrenia and bipolar disorder: from human gene expression profiles to mouse models. Neurobiol Dis (2011) 0.86
Effects of typical and atypical antipsychotic drugs on gene expression profiles in the liver of schizophrenia subjects. BMC Psychiatry (2009) 0.85
Genome-Wide Association Study with Targeted and Non-targeted NMR Metabolomics Identifies 15 Novel Loci of Urinary Human Metabolic Individuality. PLoS Genet (2015) 0.84
An integrative functional genomics approach for discovering biomarkers in schizophrenia. Brief Funct Genomics (2011) 0.83
Expression profiles of mitochondrial genes in the frontal cortex and the caudate nucleus of developing humans and mice selectively bred for high and low fear. PLoS One (2012) 0.83
Co-expression network of neural-differentiation genes shows specific pattern in schizophrenia. BMC Med Genomics (2015) 0.82
Genetic association of the Phosphoinositide-3 kinase in schizophrenia and bipolar disorder and interaction with a BDNF gene polymorphism. Brain Behav (2011) 0.82
Social stress increases expression of hemoglobin genes in mouse prefrontal cortex. BMC Neurosci (2014) 0.81
Variants in the 15q25 gene cluster are associated with risk for schizophrenia and bipolar disorder. Psychiatr Genet (2013) 0.80
The mGluR2/3 agonist LY379268 blocks the effects of GLT-1 upregulation on prepulse inhibition of the startle reflex in adult rats. Neuropsychopharmacology (2010) 0.80
Genome-wide association study of 40,000 individuals identifies two novel loci associated with bipolar disorder. Hum Mol Genet (2016) 0.79
Epigenomic profiling of preterm infants reveals DNA methylation differences at sites associated with neural function. Transl Psychiatry (2016) 0.78
Molecular profile of dissociative drug ketamine in relation to its rapid antidepressant action. BMC Genomics (2016) 0.77
Decreased Npas4 and Arc mRNA Levels in the Hippocampus of Aged Memory-Impaired Wild-Type But Not Memory Preserved 11β-HSD1 Deficient Mice. J Neuroendocrinol (2016) 0.77
Consistently altered expression of gene sets in postmortem brains of individuals with major psychiatric disorders. Transl Psychiatry (2016) 0.76
Hepatocyte nuclear factor 4 alpha is a key factor related to depression and physiological homeostasis in the mouse brain. PLoS One (2015) 0.75
Family with sequence similarity 107: A family of stress responsive small proteins with diverse functions in cancer and the nervous system (Review). Biomed Rep (2014) 0.75
Copy Number Variations in DISC1 and DISC1-Interacting Partners in Major Mental Illness. Mol Neuropsychiatry (2015) 0.75
Impaired neurodevelopment by the low complexity domain of CPEB4 reveals a convergent pathway with neurodegeneration. Sci Rep (2016) 0.75
Genes involved in pruning and inflammation are enriched in a large mega-sample of patients affected by Schizophrenia and Bipolar Disorder and controls. Psychiatry Res (2015) 0.75
Ethical and public policy challenges for pharmacogenomics. Dialogues Clin Neurosci (2014) 0.75
Transcriptome sequencing of the choroid plexus in schizophrenia. Transl Psychiatry (2016) 0.75
Molecular mechanisms underlying noncoding risk variations in psychiatric genetic studies. Mol Psychiatry (2017) 0.75
Transcriptome Alterations in Prefrontal Pyramidal Cells Distinguish Schizophrenia From Bipolar and Major Depressive Disorders. Biol Psychiatry (2017) 0.75
Identification of a Bipolar Disorder Vulnerable Gene CHDH at 3p21.1. Mol Neurobiol (2016) 0.75
A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci U S A (2004) 44.81
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science (2003) 16.14
A neurotrophic model for stress-related mood disorders. Biol Psychiatry (2006) 8.97
Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet (2002) 7.40
ErmineJ: tool for functional analysis of gene expression data sets. BMC Bioinformatics (2005) 4.98
The beginning of the end for the Kraepelinian dichotomy. Br J Psychiatry (2005) 4.51
The genetics of schizophrenia and bipolar disorder: dissecting psychosis. J Med Genet (2005) 4.02
Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. Schizophr Bull (2005) 3.93
Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry (2004) 3.90
Genes for schizophrenia? Recent findings and their pathophysiological implications. Lancet (2003) 3.61
Hippocampal neurogenesis: regulation by stress and antidepressants. Biol Psychiatry (2006) 2.94
Effect of agonal and postmortem factors on gene expression profile: quality control in microarray analyses of postmortem human brain. Biol Psychiatry (2004) 2.53
Gender-specific gene expression in post-mortem human brain: localization to sex chromosomes. Neuropsychopharmacology (2004) 2.48
Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proc Natl Acad Sci U S A (2005) 2.38
Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions. Hum Mol Genet (2004) 2.33
Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Hum Mol Genet (2004) 2.31
Molecular evidence for mitochondrial dysfunction in bipolar disorder. Arch Gen Psychiatry (2004) 2.27
The genetic deconstruction of psychosis. Schizophr Bull (2007) 2.25
A microarray gene expression study of the molecular pharmacology of lithium carbonate on mouse brain mRNA to understand the neurobiology of mood stabilization and treatment of bipolar affective disorder. Pharmacogenet Genomics (2007) 2.13
Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia. Biol Psychiatry (2007) 2.12
Molecular aging in human prefrontal cortex is selective and continuous throughout adult life. Biol Psychiatry (2005) 2.06
The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS. J Neurochem (1999) 2.04
Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders. Mol Psychiatry (2004) 1.95
Role of neurotrophic factors in the etiology and treatment of mood disorders. Neuromolecular Med (2004) 1.94
The neuregulin-I/ErbB signaling system in development and disease. Adv Anat Embryol Cell Biol (2007) 1.87
Deficient hippocampal neuron expression of proteasome, ubiquitin, and mitochondrial genes in multiple schizophrenia cohorts. Biol Psychiatry (2005) 1.76
Antidepressants and neuroplasticity. Bipolar Disord (2002) 1.66
Methodological considerations for gene expression profiling of human brain. J Neurosci Methods (2007) 1.59
Sample matching by inferred agonal stress in gene expression analyses of the brain. BMC Genomics (2007) 1.54
Differential regulation of brain derived neurotrophic factor transcripts by antidepressant treatments in the adult rat brain. Neuropharmacology (2003) 1.53
Quality control for microarray analysis of human brain samples: The impact of postmortem factors, RNA characteristics, and histopathology. J Neurosci Methods (2007) 1.44
Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders. Mol Psychiatry (2006) 1.38
Sex genes for genomic analysis in human brain: internal controls for comparison of probe level data extraction. BMC Bioinformatics (2003) 1.36
Striatal excitatory amino acid transporter transcript expression in schizophrenia, bipolar disorder, and major depressive disorder. Neuropsychopharmacology (2002) 1.33
Brain pH has a significant impact on human postmortem hippocampal gene expression profiles. Brain Res (2006) 1.31
Comparison of microarray-based mRNA profiling technologies for identification of psychiatric disease and drug signatures. J Neurosci Methods (2004) 1.26
Downregulation in components of the mitochondrial electron transport chain in the postmortem frontal cortex of subjects with bipolar disorder. J Psychiatry Neurosci (2006) 1.17
Expression of excitatory amino acid transporter transcripts in the thalamus of subjects with schizophrenia. Am J Psychiatry (2001) 1.14
Widespread expression of ErbB2, ErbB3 and ErbB4 in non-human primate brain. Brain Res (2007) 1.07
Distribution of the glutamate transporters GLT-1 (SLC1A2) and GLAST (SLC1A3) in peripheral organs. Anat Embryol (Berl) (2006) 0.96
Regulation of neurogenesis and angiogenesis in depression. Curr Neurovasc Res (2004) 0.96
Quantitative analysis of glutamate transporter mRNA expression in prefrontal and primary visual cortex in normal and schizophrenic brain. Neuroscience (2005) 0.90
Association study of polymorphisms in the excitatory amino acid transporter 2 gene (SLC1A2) with schizophrenia. BMC Psychiatry (2004) 0.90
Neurodevelopment and mood stabilizers. Curr Mol Med (2003) 0.85
The mGlu2/3 receptor agonist LY354740 suppresses immobilization stress-induced increase in rat prefrontal cortical BDNF mRNA expression. Neurosci Lett (2006) 0.85
Symptom dimensions and the Kraepelinian dichotomy. Br J Psychiatry (2007) 0.83
Apoptosis in schizophrenia: pathophysiologic and therapeutic considerations. Curr Opin Psychiatry (2006) 0.83
Schizophrenia, IV: neuregulin-1 in the human brain. Am J Psychiatry (2003) 0.79
Autoradiography of [3H]aspartate and glutamate transport in schizophrenia. Neuropsychopharmacology (2006) 0.78
Analysis of microarray data using Z score transformation. J Mol Diagn (2003) 6.82
Application of z-score transformation to Affymetrix data. Appl Bioinformatics (2003) 2.56
Effect of agonal and postmortem factors on gene expression profile: quality control in microarray analyses of postmortem human brain. Biol Psychiatry (2004) 2.53
Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions. Hum Mol Genet (2004) 2.33
Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression. PLoS One (2009) 1.78
Analysis of whole genome biomarker expression in blood and brain. Am J Med Genet B Neuropsychiatr Genet (2010) 1.63
Circadian patterns of gene expression in the human brain and disruption in major depressive disorder. Proc Natl Acad Sci U S A (2013) 1.63
Methodological considerations for gene expression profiling of human brain. J Neurosci Methods (2007) 1.59
Sample matching by inferred agonal stress in gene expression analyses of the brain. BMC Genomics (2007) 1.54
Mitochondrial involvement in psychiatric disorders. Ann Med (2008) 1.38
Mitochondrial variants in schizophrenia, bipolar disorder, and major depressive disorder. PLoS One (2009) 1.36
Identifying gene regulatory networks in schizophrenia. Neuroimage (2010) 1.34
Target identification for CNS diseases by transcriptional profiling. Neuropsychopharmacology (2008) 1.32
CRY2 is associated with depression. PLoS One (2010) 1.23
SNAP-25 reduction in the hippocampus of patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2003) 1.21
Increased fibronectin expression in sturge-weber syndrome fibroblasts and brain tissue. Pediatr Res (2003) 1.21
Loss of nuclear factor E2-related factor 1 in the brain leads to dysregulation of proteasome gene expression and neurodegeneration. Proc Natl Acad Sci U S A (2011) 1.20
Analysis of miR-137 expression and rs1625579 in dorsolateral prefrontal cortex. J Psychiatr Res (2013) 1.20
Microarray technology: a review of new strategies to discover candidate vulnerability genes in psychiatric disorders. Am J Psychiatry (2003) 1.19
NCAM1 association study of bipolar disorder and schizophrenia: polymorphisms and alternatively spliced isoforms lead to similarities and differences. Psychiatr Genet (2007) 1.16
A splice donor mutation in NAA10 results in the dysregulation of the retinoic acid signalling pathway and causes Lenz microphthalmia syndrome. J Med Genet (2014) 1.01
Gene expression changes in the prefrontal cortex, anterior cingulate cortex and nucleus accumbens of mood disorders subjects that committed suicide. PLoS One (2012) 1.01
AF5, a CNS cell line immortalized with an N-terminal fragment of SV40 large T: growth, differentiation, genetic stability, and gene expression. Exp Neurol (2002) 1.00
Mitochondrial mutations and polymorphisms in psychiatric disorders. Front Genet (2012) 0.98
Next generation sequence analysis and computational genomics using graphical pipeline workflows. Genes (Basel) (2012) 0.97
The first decade and beyond of transcriptional profiling in schizophrenia. Neurobiol Dis (2011) 0.95
Exon expression in lymphoblastoid cell lines from subjects with schizophrenia before and after glucose deprivation. BMC Med Genomics (2009) 0.93
Conserved chromosome 2q31 conformations are associated with transcriptional regulation of GAD1 GABA synthesis enzyme and altered in prefrontal cortex of subjects with schizophrenia. J Neurosci (2013) 0.90
P2RX7: expression responds to sleep deprivation and associates with rapid cycling in bipolar disorder type 1. PLoS One (2012) 0.89
Ketamine influences CLOCK:BMAL1 function leading to altered circadian gene expression. PLoS One (2011) 0.87
Application of microarray technology in primate behavioral neuroscience research. Methods (2006) 0.86
Lack of association to a NRG1 missense polymorphism in schizophrenia or bipolar disorder in a Costa Rican population. Schizophr Res (2011) 0.83
Changes in hippocampal gene expression after neuroprotective activation of group I metabotropic glutamate receptors. Brain Res Mol Brain Res (2003) 0.80
Neuropsychological performance as endophenotypes in extended schizophrenia families from the Central Valley of Costa Rica. Psychiatr Genet (2009) 0.79
Increased CNV-region deletions in mild cognitive impairment (MCI) and Alzheimer's disease (AD) subjects in the ADNI sample. Genomics (2013) 0.78
Coding and noncoding gene expression biomarkers in mood disorders and schizophrenia. Dis Markers (2013) 0.78